Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody, is utilized in hemophilia research [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody, is utilized in hemophilia research [1] [2]. |
In vitro | Marstacimab at concentrations of 20, 50, and 100 nmol/L reduced corn trypsin inhibitor (CT) levels in whole blood samples from patients with hemophilia [1]. |
In vivo | Marstacimab, administered intravenously at a dosage of 0.5 mg/kg, does not affect the hemodynamic status in a murine acute hemorrhage model [2]. |
Synonyms | PF-06741086 |
Molecular Weight | N/A |
CAS No. | 1985638-39-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Marstacimab 1985638-39-8 PF-06741086 inhibitor inhibit